Antiviral treatment attenuates hepatitis B virus reactivation after radiotherapy for hepatocellular carcinoma | EASL

Access to the full content of this site is available only to registered healthcare professionals. Register to read more

Takeaway

  • Antiviral treatment attenuates hepatitis B virus (HBV) reactivation after radiotherapy (RT) for hepatocellular carcinoma (HCC). 

Why this matters

  • There are no convincing data supporting the routine use of preventive therapy against hepatitis B virus (HBV) reactivation in ra...